Return to program book search
Herpes Zoster: Controversies and Conundrums in Treatment and Prevention
Monday, March 24
7:15 AM - 8:45 AM
Lorraine L. Rosamilia, MD, FAAD - Handout
Following this course, the attendee should be able to:
- Summarize the pathogenesis and key clinical features of herpes zoster, including unique presentations in special patient populations.
- Identify the best treatment regimens for herpes zoster based on recent literature, including evidence for and against measures to manage post-herpetic neuralgia.
- Outline, using case scenarios, systems-based prevention strategies for herpes zoster in health care institutions, including updated vaccination guidelines and hospital isolation policies.
During an inpatient consult for herpes zoster, have you ever been approached by a frantic staff or family member, worried that a pregnant, elderly, or infant contact will be 'infected' if they get too close? Have your patients ever asked you about their risk of having herpes zoster twice? Should they be vaccinated? What are the costs? Risks? In what timeline should antiviral therapy be employed? Is there evidence for prednisone or gabapentin? In case-based form, these and other complex but common scenarios will be examined using viral mechanistic and clinical clues and updated prevention and treatment guidelines.